Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data SkyAI, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2022
FY2022
FY2023
FY2024
FY2025
Revenue
0.2
Cost of revenue
0.62
Gross profit
-0.41
Research and development
1.69
2.28
1.61
0.53
0.2
Selling, general and administrative
5.04
16.1
General and administrative
2.81
6.46
8.52
7.15
Operating expenses
4.5
8.74
10.1
5.57
276
Operating income
-4.5
-8.74
-10.1
-5.57
-270
Interest expense
1.66
0.42
Other non-operating income
0.03
0.34
-0.6
Pre-tax income
-4.64
-9.87
-5.23
-270
Income tax
-0.03
-0.03
Net income
-4.66
-4.64
-9.84
-9.3
-283
EBITDA
-4.47
-8.08
-9.24
-5.53
-270
EPS, basic
-6,294.00
-3,737.00
-4,983.00
-2,220.00
-11.16
EPS, diluted
-6,294.00
-3,737.00
-4,983.00
-2,220.00
-11.16
Shares, basic (weighted)
0
0
0
0
25.3
Shares, diluted (weighted)
0
0
0
0
25.3
Balance sheet
FY2022
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
1.48
4.17
3.01
0.75
10.4
Inventory
0.12
0.19
1.71
0.54
0.65
Other current assets
0.01
0.07
0.07
0.08
0.48
Total current assets
1.61
4.42
4.84
3.17
18.9
Property, plant and equipment
3.76
7
6.82
1.18
0.08
Intangible assets
0.06
0.05
0.03
Other non-current assets
0.53
0.41
0.13
0.07
0
Total assets
5.9
11.8
11.8
7.31
269
Accounts payable
0.8
0.54
0.79
0.69
0.59
Short-term debt
3.08
Total current liabilities
2.77
2.01
3.69
5.19
4.7
Total liabilities
2.77
2.2
3.85
5.32
4.7
Paid-in capital
13.8
24.7
32.5
36.4
581
Retained earnings
-10.7
-15.3
-25.1
-34.4
-317
Other comprehensive income
0.21
0.59
0.02
Shareholders' equity
3.14
9.64
7.93
2
264
Total equity
3.14
9.64
7.93
2
264
Total liabilities and equity
5.9
11.8
11.8
7.31
269
Shares outstanding
0
0
0
0.01
29
Cash flow statement
FY2022
FY2022
FY2023
FY2024
FY2025
Net income
-4.66
-4.64
-9.84
-9.3
-283
Depreciation and amortization
0.03
0.65
0.88
0.04
0.13
Stock-based compensation
1.2
1.01
0.96
0.52
5.88
Deferred income tax
-0.03
-0.03
Change in receivables
-0.2
Change in inventory
-0.12
-0.03
-1.44
-0.35
-0.3
Change in payables
0.2
-0.1
0.42
0.1
0.24
Cash from operations
-3.15
-6.43
-8.51
-4.4
-11
Capital expenditures
-2.22
-0.54
-0.7
-0.14
Cash from investing
-2.34
-3.12
-0.7
-1
-188
Debt issued
2.74
Debt repaid
-0.2
-4.22
Stock issued
3.38
Cash from financing
5.18
12.2
8.03
5.91
216
Net change in cash
-0.31
2.69
-1.16
-2.15
Free cash flow
-5.37
-6.98
-9.21
-4.54
Interest paid
0
0.05
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $1.88 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
186.4%
Gross profit / revenue.
Operating margin
-216,217.0%
Operating income / revenue.
EBITDA margin
-216,178.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-221,236.0%
Pre-tax income / revenue.
Net margin
-228,221.0%
Net income / revenue.
Operating cash flow margin
-8,259.0%
Cash from operations / revenue.
Return on equity (ROE)
-252.7%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-247.9%
Net income / average total assets.
Return on invested capital (ROIC)
-204.9%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
273.0%
Research and development expense / revenue.
SG&A / revenue
12,870.0%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
5,877.0%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
38.8%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Book value growth, 1y
13,145.0%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
201.6%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
3,579.0%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
183.3%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y
604,142.0%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
2,636.0%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
5.35x
Current assets / current liabilities.
Quick ratio
4.16x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
4.16x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.00
Revenue / diluted weighted shares.
Operating cash flow per share
-$0.20
Cash from operations / diluted weighted shares.
Book value per share
$3.66
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
464x
Market cap / revenue.
P/B
0.51x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
0.51x
Market cap / tangible book value, when positive.
EV/Sales
395x
Enterprise value / revenue.
Earnings yield
-491.9%
Net income / market cap (the inverse of P/E).
What was SkyAI, Inc.'s revenue in fiscal 2025?
SkyAI, Inc. reported revenue of $204.1K for fiscal 2025.
Was SkyAI, Inc. profitable in fiscal 2025?
No. It reported a net loss of $282.5M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.